1. FDA approves Sarepta’s DMD drug that it had previously rejected — Biogen chalks up another failure — The House passes the Lower Drug Costs Now Act, but it’s unlikely to become law — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Pharma/Biotech Companies - Stock Discussions

An anonymous board for discussion on the stocks of pharma and biotech companies


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    1,859
  2. anonymous
    Replies:
    0
    Views:
    439
  3. RobertPhillips900
    Replies:
    13
    Views:
    3,221
  4. Jim Rogers
    Replies:
    1
    Views:
    2,911
  5. Jim Rogers
    Replies:
    0
    Views:
    1,418
  6. Norman Foster
    Replies:
    0
    Views:
    1,323
  7. DonnyD2017
    Replies:
    1
    Views:
    2,345
  8. anonymous
    Replies:
    22
    Views:
    12,960
  9. Harrison Lockridge
    Replies:
    0
    Views:
    1,384
  10. anonymous
    Replies:
    0
    Views:
    1,636
  11. anonymous
    Replies:
    0
    Views:
    2,428
  12. RobertPhillips900
    Replies:
    0
    Views:
    1,569
  13. RobertPhillips900
    Replies:
    0
    Views:
    1,497
  14. anonymous
    Replies:
    5
    Views:
    2,548
  15. HedgeFund House
    Replies:
    13
    Views:
    5,846

Thread Display Options

Loading...